- Company
SR Score
639
SR Web
600
Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.
Acquired by Celldex Therapeutics on November 01, 2016
Website: https://www.kolltan.com
Founded: January 01, 2007
Social:
